Search
US advisory panel endorses 'breakthrough' gene therapy for child cancer
- OPACC
- Jul 13, 2017
- 1 min read
An FDA advisory panel has unanimously approved a leukemia treatment that could become the first gene therapy approved in the US. The panel hailed the drug as a "major advance" in the battle against childhood cancer.
Recent Posts
See AllWhile the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...